Pay in 4 interest-free payments of $5.23 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Unlike some peptides that require cycling to prevent receptor desensitization, AOD-9604 does not appear to lose efficacy with continuous use based on available data
Measurable changes in body composition typically become noticeable after 8 to 12 weeks of consistent use
The answer is not simple
Frequency: one subcutaneous injection each day , increasing by roughly 100 mcg every 24 weeks as tolerated
If the procedure started as a screening and a biopsy was taken, replace the screening code with 45380, then append modifier PT (Medicare) or modifier 33 (commercial)
US$ 21.08
US$ 25.02
US$ 29.00
US$ 20.22
US$ 27.32
US$ 24.08
